Pharma & Biotech

Adma Biologics is currently navigating a period of significant internal transformation. The company's renewed strategic emphasis is on strengthening its...

Profound Medical's latest financial report reveals a company in a pivotal transition phase. The medical technology firm released its fourth-quarter...

During a recent investor roadshow, healthcare conglomerate Fresenius provided a detailed look at its strategic priorities and risk assessment. The...

Bayer's latest financial results present a stark dichotomy. While the company's core business operations demonstrate resilience, its bottom line continues...

ImmunityBio's impressive full-year 2025 results were met with a severe sell-off, highlighting the persistent volatility that continues to characterize this...

Investor focus returns to Viking Therapeutics next week as company executives prepare to outline their strategic vision at two major...

While demand for weight-loss medications remains robust, inconsistent insurance coverage continues to be a significant barrier for many patients. Pharmaceutical...

Despite securing two significant regulatory approvals from the U.S. Food and Drug Administration (FDA) in early March 2026, shares of...

The pharmaceutical giant AbbVie is finding an unexpected growth opportunity in the surge of popularity for weight-loss drugs. While medications...

Axsome Therapeutics is making a bold and resource-intensive move to significantly expand its commercial operations. The biopharmaceutical company has announced...